Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05313087 · ClinicalTrials.gov registry record
COVID-19 Vaccine Response in Chronic Respiratory Conditions
A clinical trial, sponsored by National Jewish Health.
- Completed
- Registry status
- 360
- Enrollment target
NCT05313087 is a clinical trial that has completed, run by National Jewish Health. The registered enrollment target is 360 participants.
The verdict
NCT05313087 has completed, sponsored by National Jewish Health.
- COMPLETED
- Registry status
- 360 participants
- Enrollment target
Study Summary
The investigators will assess the antibody, T cell and B cell responses to SARS-CoV-2 vaccination before and every 3 months for 18 months after the initial vaccination or subsequent vaccinations (boosters) in adults and children including patients with chronic medical conditions.
Interventions
- BIOLOGICAL COVID-19 vaccine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 360 participants |
| Start Date | 2021-02-03 |
| Est. Completion | 2023-12-30 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05313087
The ClinicalTrials.gov registry entry for NCT05313087 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 360 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National Jewish Health, which has 83 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which COVID-19 vaccine is the first listed.
NCT05313087 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05313087 about?
NCT05313087 is a clinical study titled "COVID-19 Vaccine Response in Chronic Respiratory Conditions". The investigators will assess the antibody, T cell and B cell responses to SARS-CoV-2 vaccination before and every 3 months for 18 months after the initial vaccination or subsequent vaccinations (boosters) in adults and children including patients with chronic medical conditions.
What is the current status of trial NCT05313087?
This trial is currently completed. The enrollment target is 360 participants. The study started on 2021-02-03. Estimated completion is 2023-12-30.
What interventions are being tested in trial NCT05313087?
The interventions under investigation include: COVID-19 vaccine (BIOLOGICAL).
Who is sponsoring clinical trial NCT05313087?
This trial is sponsored by National Jewish Health, which has 83 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.